Maverix Medical Acquires Cirrus Bio
March 29, 2024
Maverix Medical, a lung cancer platform backed by Ajax Health, KKR, and Hologic, has acquired Cirrus Bio to form the foundation of a new diagnostics division, Maverix Dx. Cirrus Bio's multiomic diagnostic capabilities and its founders, David Mallery (CEO) and Scott Morris (CSO), will lead Maverix Dx as the platform pursues further diagnostic product development and M&A.
- Buyers
- Maverix Medical, Ajax Health, KKR, Hologic, Inc.
- Targets
- Cirrus Bio
- Platforms
- Maverix Medical
- Industry
- Biotechnology
- Location
- United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
Chimerix Acquires Oncoceutics
January 7, 2021
Biotechnology
Chimerix (NASDAQ: CMRX) acquired clinical-stage Oncoceutics, gaining the late-stage oncology candidate ONC201 to expand its oncology pipeline. The deal closed January 7, 2021, for $78 million (half stock, half cash) plus potential milestones and royalties.
-
Cloud Equity Group Acquires Cirrus Hosting and HostMDS
December 28, 2020
Cloud & SaaS
Cloud Equity Group, a New York–based private equity firm focused on web hosting and cloud infrastructure, acquired Canadian hosting providers Cirrus Hosting and HostMDS, both headquartered in Toronto. The purchases expand Cloud Equity Group’s platform in the web hosting/cloud space and position the combined business to accelerate growth organically and via further acquisitions.
-
Carbon60 Acquires Cirrus9
December 17, 2019
IT Services
Carbon60, a PE-backed managed cloud services provider, has acquired Cirrus9, a Saint John, New Brunswick-based managed cloud and hosting provider, to establish an Atlantic Canada presence and create a national footprint. The deal, completed with support from advisor RBC, expands Carbon60’s managed public/private cloud, hosting and security capabilities for Canadian enterprise and public-sector clients.
-
Bruker Corporation Acquires Canopy Biosciences, LLC
September 11, 2020
Biotechnology
Bruker Corporation has acquired Canopy Biosciences, LLC to strengthen its targeted multi-omics and high-plex biomarker imaging capabilities, adding Canopy's ChipCytometry platform and multi-omics services. Financial terms were not disclosed; Ampersand Capital Partners was identified as Canopy's lead investor.
-
Mirion Technologies Acquires Biodex Medical Systems
September 1, 2020
Medical Devices
Mirion Technologies, a San Ramon-based, PE-backed provider of radiation detection and measurement solutions, acquired Biodex Medical Systems, Inc. effective September 1, 2020. Biodex, a manufacturer of nuclear medicine instruments, medical imaging equipment and rehabilitation systems headquartered in Shirley, New York, will expand Mirion's medical device and imaging capabilities as part of Mirion's strategic plan to grow its medical business.
-
Medical Laboratory Diagnostics (MedLabs) Acquires Mercy Diagnostics
April 1, 2019
Healthcare Services
Caymus Equity Partners’ portfolio company Medical Laboratory Diagnostics, LLC (MedLabs) acquired Mercy Diagnostics, Inc., a Mount Laurel, New Jersey clinical diagnostics laboratory. The add-on transaction closed on April 24, 2019 and is MedLabs’ first strategic acquisition since the company’s majority recapitalization in March 2018.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.